Skip to content

The Third Epidemiological Research of Refractory Wounds in China

The Third Epidemiological Research of Refractory Wounds in China

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04958850
Enrollment
500
Registered
2021-07-12
Start date
2018-01-01
Completion date
2018-12-31
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound of Skin

Keywords

cutaneous wounds, epidemiology, China

Brief summary

This study is a cross-sectional survey in patients who underwent treatment of chronic cutaneous wounds from a nationally representative sample in our hospital from January 2018 to December 2018.

Detailed description

Chronic cutaneous wounds represent a major health care burden in China However, limited information exists regarding the epidemiologic changes associated with recent social and economic devdopment.We designed a cross-sectional survey in patients who underwent treatment of chronic cutaneous wounds from a nationally representative sample in our hospital from January 2018 to December 2018.

Interventions

OTHERa cross-sectional survey

Collect the data of this year and compare it with that of ten years ago

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

\- Patients who underwent treatment of chronic cutaneous wounds in our hospital from 1/2018-12/2018.

Exclusion criteria

\- No

Design outcomes

Primary

MeasureTime frameDescription
the prevalence of chronic cutaneous wounds among hospitalized patients1 yearAll the patients with refractory wounds on the body surface

Secondary

MeasureTime frameDescription
cause of disease1 yeardiabetes, trauma or other.
Bacterial etiology1 yearpatients had results of bacterial cultivation
Treatment expense1 yearTreatment was paid by the patients, social medical insurance, commercial medical insurance, or free medical care.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026